WB result of STIM1 Recombinant Rabbit mAb
Primary antibody: STIM1 Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: PANC-1 whole cell lysate 20 µg
Lane 2: K-562 whole cell lysate 20 µg
Lane 3: HeLa whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 77 kDa
Observed MW: 95 kDa
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | STIM1 |
| Location | Cytoplasm, Cytoskeleton, Cell membrane, Endoplasmic reticulum membrane |
| Accession | Q13586 |
| Clone Number | S-6524 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | WB |
| Reactivity | Hu, Ms, Mk |
| Positive Sample | PANC-1, K-562, HeLa, NIH/3T3, A20, RAW 264.7, COS-7 |
| Predicted Reactivity | Rt |
| Purification | Protein A |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| WB | 1:1000 | Hu, Ms, Mk |
Background
STIM1 (stromal interaction molecule 1) is a single-pass transmembrane calcium sensor protein localized to the endoplasmic reticulum (ER) membrane that serves as the core initiator of store-operated calcium entry (SOCE), responsible for sensing depletion of ER luminal calcium stores and transmitting this signal to the Orai1 calcium channels on the plasma membrane. Its luminal N-terminus contains EF-hand and SAM domains, which maintain an autoinhibited conformation through EF-hand–SAM interactions when stores are replete; upon store depletion and calcium dissociation, EF-SAM oligomerizes, and the cytosolic coiled-coil domains then drive STIM1 to form puncta at ER–plasma membrane contact sites, where it directly binds and activates Orai1 channels via the SOAR/CAD domain. In the resting state, STIM1 activity is cooperatively restrained by multiple weak inhibitory interactions, including steric occlusion by the calcium-bound EF-SAM, exchange interactions between CC1α1 and CC3, electrostatic lipid interactions between the CAD tip and the ER membrane, and hydrophobic and electrostatic constraints from CC1α2/3; disruption of any one of these restraints can lead to spontaneous STIM1 activation. Clinically, biallelic loss-of-function mutations in STIM1 cause severe immunodeficiency with hypotonia and autoimmune manifestations, whereas gain-of-function mutations cause tubular aggregate myopathy and Stormorken syndrome, characterized by muscle weakness, thrombocytopenia, asplenia, and short stature.
Picture
Picture
Western Blot
WB result of STIM1 Recombinant Rabbit mAb
Primary antibody: STIM1 Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: NIH/3T3 whole cell lysate 20 µg
Lane 2: A20 whole cell lysate 20 µg
Lane 3: RAW 264.7 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 77 kDa
Observed MW: 90 kDa
WB result of STIM1 Recombinant Rabbit mAb
Primary antibody: STIM1 Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: COS-7 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 77 kDa
Observed MW: 90 kDa
